Skip to main content
. 2010 Sep 7;6(4):533–538. doi: 10.5114/aoms.2010.14464

Table II.

Modification of antihypertensive treatment during IAT

Number of drugs per patient Before IAT (n=18) IAT (n=18)
n Treatment n Treatment
0 7 0
1 6 (1×BB) 11 (5×BB)
(1×CCB) (2×CCB)
(4×ACE-I) (4×ACE-I)
2 3 (2×ACE-I+D) 4 (2×BB+D)
(1×CCB+D) (1×ACE-I+D)
(1×CCB+D)
3 2 (1×CCB+ACE-I+D) 1 (1×CCB+ACE-I+D)
(1×BB+CCB+D)
4 0 2 (2×BB+CCB+ACE-I+D)

BB – β-blocker, CCB – calcium channel blocker, ACE-I – inhibitor of angiotensin-converting enzyme, D – thiazide diuretic